IFR US ECM Calendar
October 27: MapLight Therapeutics (US, biotech) – $250.8m IPO. 14.8m shares (Primary) at $17.00 fixed price. MS, JEFF, LEER, STFL. Nasdaq "MPLT". Pricing date based on automatic effectiveness 20 days from 10/6 S-1/A filing. T. Rowe Price indicated for $40m of offering. Goldman Sachs affiliate investing $8.1m through a concurrent private placement.
October 30: Navan (US, software) – $960m IPO. 36.9m shares (Primary, Secondary) at $24-$26. GS, CITI. Nasdaq “NAVN”. Pricing date based on automatic effectiveness 20 days from 10/6 S-1/A filing. Selling shareholders led by co-founders Ariel Cohen and Ilan Twig.
November 3: Beta Technologies (US, EV aircraft) – $825m IPO. 25m shares (Primary) at $27-$33. MS, GS. NYSE “BETA”. Alliance Bernstein, BlackRock, company director Chuck Davis, GE Aerospace and Federated have indicated for $300m combined of offering. 5% DSP.
November 4: Exzeo Group (US, insurtech) ─ $176m IPO. 8m shares (Primary) at $20.00-$22.00. TRST, CITZ, WBLR. NYSE “XZO”. Pricing date based on automatic effectiveness 20 days from 10/16 S-1/A filing. Spin-off from HCI Group. 5% DSP.
November 6: Evommune (US, biotech) ─ $159.4m IPO. 9.4m shares (Primary) at $15.00-$17.00. MS, LEER, EVER, CANT. NYSE "EVMN". Pricing date based on automatic effectiveness 20 days from 10/17 S-1/A filing.